Literature DB >> 2764526

Clinical comparison of single-oral-dose cefuroxime axetil and amoxicillin with probenecid for uncomplicated gonococcal infections in women.

L M Baddour1, R S Gibbs, G Mertz, D M Cocchetto, R C Noble.   

Abstract

Four hundred sixty-six female patients were enrolled in a randomized study that compared the clinical efficacies of single oral doses of cefuroxime axetil and amoxicillin with probenecid in the treatment of uncomplicated gonorrhea. Two hundred ninety-five patients had culture-positive gonococcal infections and completed the investigation. Cure rates for the patients treated with cefuroxime axetil and those treated with amoxicillin with probenecid were high (greater than 95%) for genitorectal infections. Pharyngeal infections, however, were not uniformly eradicated by either cefuroxime axetil (60%) or amoxicillin with probenecid (64%). Approximately 13% of each patient group suffered adverse events, which were gastrointestinal in the majority and were transient. Compared with amoxicillin plus probenecid, cefuroxime axetil in a single oral dose was an equally safe and effective drug for the treatment of uncomplicated gonorrhea in women caused by penicillin-susceptible strains.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2764526      PMCID: PMC284233          DOI: 10.1128/AAC.33.6.801

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

1.  Pharyngeal neisseria gonorrhoeae: coloniser or pathogen?

Authors:  J Wallin; M S Siegel
Journal:  Br Med J       Date:  1979-06-02

2.  Treatment of Females with Acute Gonorrhœa using Cefuroxime.

Authors:  I Moberg; K Wennberg
Journal:  Proc R Soc Med       Date:  1977

3.  Cefuroxime and post-gonococcal urethritis.

Authors:  W Fowler; G Rahim
Journal:  Proc R Soc Med       Date:  1977

4.  Clinical spectrum of pharyngeal gonococcal infection.

Authors:  P J Wiesner; E Tronca; P Bonin; A H Pedersen; K K Holmes
Journal:  N Engl J Med       Date:  1973-01-25       Impact factor: 91.245

5.  Cefuroxime axetil for treatment of uncomplicated gonorrhea.

Authors:  A Gottlieb; J Mills
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

6.  Clinical experience in the use of cefuroxime in gonorrhoea.

Authors:  W Fowler; G Rahim; J D Brown
Journal:  Br J Vener Dis       Date:  1978-12

7.  Cefuroxime compared with penicillin for the treatment of gonorrhea.

Authors:  G D Morrison; A J Evans; H W Haskins; N M Lewis; G H Seale; E Mayall; B M Mullinger
Journal:  Sex Transm Dis       Date:  1980 Oct-Dec       Impact factor: 2.830

8.  Cefuroxime, thiamphenicol, spectinomycin, and penicillin G in uncomplicated infections due to penicillinase-producing strains of Neisseria gonorrhoeae.

Authors:  T E Tupasi; L B Crisologo; C A Torres; O V Calubiran; I de Jesus
Journal:  Br J Vener Dis       Date:  1983-06

9.  Comparative in vitro activity of cefmenoxime, cefotaxime, cefuroxime, cefoxitin, and penicillin against Neisseria gonorrhoeae.

Authors:  M Y Khan; Y Siddiqui; M L Simpson; R P Gruninger
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

10.  Single-dose cefuroxime axetil in the treatment of uncomplicated gonorrhea: a controlled trial.

Authors:  R C Reichman; F S Nolte; S M Wolinsky; C A Greisberger; M A Trupei; J Nitzkin
Journal:  Sex Transm Dis       Date:  1985 Oct-Dec       Impact factor: 2.830

View more
  6 in total

Review 1.  Cefuroxime axetil: an updated review of its use in the management of bacterial infections.

Authors:  L J Scott; D Ormrod; K L Goa
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Comparison of single-dose cefuroxime axetil with ciprofloxacin in treatment of uncomplicated gonorrhea caused by penicillinase-producing and non-penicillinase-producing Neisseria gonorrhoeae strains.

Authors:  E M Thorpe; J R Schwebke; E W Hook; A Rompalo; W M McCormack; K L Mussari; G C Giguere; J J Collins
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

3.  Susceptibility of Neisseria gonorrhoeae to cefpodoxime: determination of MICs and disk diffusion zone diameters.

Authors:  T Fekete; J Woodwell; K R Cundy
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

4.  Prepackaged therapy for urethritis: the "MSTOP" experience in Cameroon.

Authors:  F Crabbé; J P Tchupo; T Manchester; T Gruber-Tapsoba; D Mugrditchian; J Timyan; G Goodridge; C Cheta; M Laga; G Dallabetta
Journal:  Sex Transm Infect       Date:  1998-08       Impact factor: 3.519

Review 5.  Cefuroxime axetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  C M Perry; R N Brogden
Journal:  Drugs       Date:  1996-07       Impact factor: 9.546

6.  Cefuroxime axetil (ceftin): a brief review.

Authors:  R D Leder; D S Carson
Journal:  Infect Dis Obstet Gynecol       Date:  1997
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.